김기현 프로필 사진

김기현

Kim, Ki Hyun

내과

혈액종양내과분과

ORCID

자료 필터

자료유형

발행연도

1999 ~ 2026
1999 2026

키워드

언어

전체 339건 중 1번부터 10번까지의 결과를 표시합니다.

2026
Article

Toxicity-Related Treatment Cessation in Newly Diagnosed Multiple Myeloma-Risk Factors and Survival: An Analysis From the APAC and ANZ Myeloma and Related Diseases Registry

  • Lee, Ji Hyun ; 
  • Kim, Sung-Hyun ; 
  • Kim, Kihyun ; 
  • Ashrafi, Elham ; 
  • Wellard, Cameron ; 
  • 외 10명
  • 2026-09-16
  • European Journal of Haematology
  • WILEY
Article

Prospective Head-To-Head Comparison of a 10-Color Single-Tube Flow Cytometry and EuroFlow Next-Generation Flow in Multiple Myeloma Minimal Residual Disease

  • 2026-09
  • Journal of Clinical Laboratory Analysis
  • WILEY
Article

Prospective, multicentre phase II study to evaluate the clinical benefit of reduced-dose lenalidomide and dexamethasone based on frailty stratification in elderly, unfit patients with newly diagnosed multiple myeloma

  • Jung, Sung-Hoon ; 
  • Kim, Dajung ; 
  • Lee, Je-Jung ; 
  • Choi, Daero ; 
  • Lee, Won Sik ; 
  • ... Kim, Kihyun ; 
  • 외 10명
  • 2026-09
  • British Journal of Haematology
  • WILEY
Article

Daratumumab-bortezomib-cyclophosphamide-dexamethasone for newly diagnosed amyloidosis: ANDROMEDA final survival analysis

  • Kastritis, Efstathios ; 
  • Palladini, Giovanni ; 
  • Minnema, Monique C. ; 
  • Wechalekar, Ashutosh D. ; 
  • Jaccard, Arnaud ; 
  • ... Kim, Kihyun ; 
  • 외 39명
  • 2026-08-27
  • Blood
  • ELSEVIER
Article

First report of daratumumab interference in urine immunofixation electrophoresis confirmed by the HYDRASHIFT 2/4 Daratumumab assay

  • 2026-08-21
  • Annals of Clinical Biochemistry
  • SAGE PUBLICATIONS INC
Article

Healthcare Jurisdiction as a Determinant of Real-World Survival in Transplant-Ineligible Multiple Myeloma: Lessons From a Three-Country East Asian Comparison

  • Byeon, Seonggyu ; 
  • Park, Sung-Soo ; 
  • Jung, Seungpil ; 
  • Choi, Suein ; 
  • Kim, Kihyun ; 
  • 외 1명
  • 2026-07-26
  • European Journal of Haematology
  • WILEY
Article

A Phase II Study of Daratumumab in Combination with Bortezomib and Dexamethasone in Patients with Multiple Myeloma Who Received One Prior Line of Therapy (KMM1906)

  • 2026-07
  • Cancer Research and Treatment
  • KOREAN CANCER ASSOCIATION
Article

Real-World Efficacy and Safety of Teclistamab for Patients with Relapsed or Refractory Multiple Myeloma: Nationwide Retrospective Analysis of the Named Patient Program in Korea

  • Yi, Jun Ho ; 
  • Lee, Jae Hoon ; 
  • Jung, Sung-Hoon ; 
  • Lee, Ji Hyun ; 
  • Lee, Ji Yun ; 
  • ... Kim, Kihyun ; 
  • 외 6명
  • 2026-07
  • Cancer Research and Treatment
  • KOREAN CANCER ASSOCIATION
Article

Response kinetics as a dynamic prognostic marker in patients with multiple myeloma

  • Cho, Hee Jeong ; 
  • Lee, Myung-Won ; 
  • Lee, Jae Hoon ; 
  • Eom, Hyeon-Seok ; 
  • Jung, Jongheon ; 
  • ... Kim, Kihyun ; 
  • 외 15명
  • 2026-07
  • Leukemia
  • SPRINGERNATURE
Article

Plain language summary of publication of how long people with relapsed multiple myeloma lived after treatment in the IKEMA study: Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone

  • Yong, Kwee ; 
  • Martin, Thomas ; 
  • Dimopoulos, Meletios-Athanasios ; 
  • Mikhael, Joseph ; 
  • Capra, Marcelo ; 
  • ... Kim, Kihyun ; 
  • 외 14명
  • 2026-06-21
  • Future Oncology
  • TAYLOR & FRANCIS LTD
12345